Characteristics of study population
| Age (years) | Gender (M/F) | Extracardiac involvement | Pre and post scan interval (months) | IS Treatment | Pre-EF (%) | Post-EF (%) | Pre-peak T2 (ms)* | Post-peak T2 (ms) | Pre-Avg T2 (ms) | Post-Avg T2 (ms) | Pre-LGE (number of segments) | Post-LGE (number of segments) | Interval cardiac status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 54 | F | Lung | 7.7 | + | 68 | 67 | 62 | 56 | 51 | 52 | 6 | 7 | Resolved SVT, NSVT |
| 41 | F | Lung | 14.9 | + | 29 | 35 | 74 | 54 | 62 | 49 | 1 | 0 | Resolved palpitations |
| 45 | M | Lung | 10.3 | + | 50 | 55 | 73 | 59 | 57 | 54 | 2 | 3 | Resolved near syncope, 80% ↓PVCs |
| 41 | M | Lung, LN, skin | 6.0 | + | 54 | 52 | 74 | 56 | 57 | 49 | 7 | 7 | Resolved LBBB |
| 60 | F | LN, spleen | 4.8 | + | 70 | 69 | 64 | 59 | 56 | 52 | 9 | 10 | Resolved palpitations, 65% ↓PVCs |
| 58 | M | Lung, eye | 28.9 | + | 78 | 67 | 73 | 71 | 55 | 56 | 7 | 6 | Resolved palpitations and NSVT |
| 52 | F | Lung | 18 | − | 50 | 35 | – | – | – | – | 1 | 4 | Near syncope, ICD placement |
| 28 | M | Lung, LN | 5.6 | Low dose | 58 | 59 | 74 | 80 | 58 | 58 | 5 | 5 | Stable PVCs |
*T2 values above 59 ms are abnormal.
EF, ejection fraction; ICD, implantable cardioverter defibrillators; IS, immune suppression; LBBB, left bundle branch block; LGE, late-gadolinium enhancement; LN, lymph nodes; NSVT, non-sustained ventricular tachycardia; PVC, premature ventricular contraction; SVT, supraventricular ventricular tachycardia.